Filter News
Area of Research
- (-) Materials (8)
- (-) National Security (13)
- (-) Nuclear Science and Technology (2)
- Advanced Manufacturing (1)
- Biology and Environment (3)
- Clean Energy (6)
- Computer Science (1)
- Fusion and Fission (1)
- Isotopes (13)
- Materials for Computing (1)
- Neutron Science (2)
- Quantum information Science (1)
- Supercomputing (18)
News Type
News Topics
- (-) Cybersecurity (15)
- (-) Frontier (2)
- (-) Isotopes (6)
- 3-D Printing/Advanced Manufacturing (17)
- Advanced Reactors (5)
- Artificial Intelligence (12)
- Bioenergy (11)
- Biology (5)
- Biomedical (3)
- Buildings (2)
- Chemical Sciences (22)
- Climate Change (6)
- Composites (3)
- Computer Science (17)
- Coronavirus (2)
- Critical Materials (8)
- Decarbonization (5)
- Energy Storage (20)
- Environment (9)
- Exascale Computing (1)
- Fusion (6)
- Grid (4)
- High-Performance Computing (3)
- ITER (1)
- Machine Learning (8)
- Materials (41)
- Materials Science (42)
- Microscopy (15)
- Molten Salt (2)
- Nanotechnology (25)
- National Security (21)
- Net Zero (1)
- Neutron Science (22)
- Nuclear Energy (17)
- Partnerships (11)
- Physics (22)
- Polymers (8)
- Quantum Computing (2)
- Quantum Science (11)
- Renewable Energy (1)
- Security (7)
- Space Exploration (2)
- Summit (1)
- Sustainable Energy (9)
- Transformational Challenge Reactor (2)
- Transportation (5)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.